nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aldehyde dehydrogenase 3a2 protects AML cells from oxidative death and the synthetic lethality of ferroptosis inducers
|
Yusuf, Rushdia Zareen |
|
|
136 |
11 |
p. 1303-1316 |
artikel |
2 |
ART and science of keeping HIV out of the blood supply
|
Kaufman, Richard |
|
|
136 |
11 |
p. 1223-1224 |
artikel |
3 |
Brandalise syndrome: a rare inclusion cell disease
|
Schell, Bérénice |
|
|
136 |
11 |
p. 1373 |
artikel |
4 |
Congenital dyserythropoietic anemias
|
Iolascon, Achille |
|
|
136 |
11 |
p. 1274-1283 |
artikel |
5 |
COVID-19 concerns aggregate around platelets
|
Battinelli, Elisabeth M. |
|
|
136 |
11 |
p. 1221-1223 |
artikel |
6 |
Curran KJ, Margossian SP, Kernan NA, et al. Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL. Blood. 2019;134(26):2361-2368.
|
|
|
|
136 |
11 |
p. 1374 |
artikel |
7 |
Detonating T-ALL
|
Mamonkin, Maksim |
|
|
136 |
11 |
p. 1218-1219 |
artikel |
8 |
Diamond-Blackfan anemia
|
Da Costa, Lydie |
|
|
136 |
11 |
p. 1262-1273 |
artikel |
9 |
Editorial Board
|
|
|
|
136 |
11 |
p. i |
artikel |
10 |
Glucose-6-phosphate dehydrogenase deficiency
|
Luzzatto, Lucio |
|
|
136 |
11 |
p. 1225-1240 |
artikel |
11 |
HIV antiretroviral therapy and prevention use in US blood donors: a new blood safety concern
|
Custer, Brian |
|
|
136 |
11 |
p. 1351-1358 |
artikel |
12 |
HIV incidence in US first-time blood donors and transfusion risk with a 12-month deferral for men who have sex with men
|
Grebe, Eduard |
|
|
136 |
11 |
p. 1359-1367 |
artikel |
13 |
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)
|
Ramos, Juan C. |
|
|
136 |
11 |
p. 1284-1297 |
artikel |
14 |
Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast
|
de Boer, Mintsje |
|
|
136 |
11 |
p. 1368-1372 |
artikel |
15 |
Introduction to a review series on inherited anemias
|
Cazzola, Mario |
|
|
136 |
11 |
p. 1215-1216 |
artikel |
16 |
Management of pyruvate kinase deficiency in children and adults
|
Grace, Rachael F. |
|
|
136 |
11 |
p. 1241-1249 |
artikel |
17 |
Myc matters in HIV-associated lymphoma
|
Witzig, Thomas E. |
|
|
136 |
11 |
p. 1217-1218 |
artikel |
18 |
No keto for AML stem cells!
|
Will, Britta |
|
|
136 |
11 |
p. 1219-1221 |
artikel |
19 |
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|
Hottz, Eugenio D. |
|
|
136 |
11 |
p. 1330-1341 |
artikel |
20 |
Platelet gene expression and function in patients with COVID-19
|
Manne, Bhanu Kanth |
|
|
136 |
11 |
p. 1317-1329 |
artikel |
21 |
Postdischarge thrombosis and hemorrhage in patients with COVID-19
|
Patell, Rushad |
|
|
136 |
11 |
p. 1342-1346 |
artikel |
22 |
Postdischarge venous thromboembolism following hospital admission with COVID-19
|
Roberts, Lara N. |
|
|
136 |
11 |
p. 1347-1350 |
artikel |
23 |
Preclinical efficacy of humanized, non–FcγR-binding anti-CD3 antibodies in T-cell acute lymphoblastic leukemia
|
Tran Quang, Christine |
|
|
136 |
11 |
p. 1298-1302 |
artikel |
24 |
Red cell membrane disorders: structure meets function
|
Risinger, Mary |
|
|
136 |
11 |
p. 1250-1261 |
artikel |